Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...
Good morning. It’s an exciting week not only for biotech M&A, but also for my city (Chicago) as we gear up for our big game ...
Indian drugmakers, known for their chemistry and prowess in making generics—cheaper copies of innovative drugs—for the world, ...
After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond ...
Investor's Business Daily on MSN
Biotech stocks' dark winter is over. What that means for investors.
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...
In the past three weeks, a flurry of licensing deals with Chinese biotechs were announced featuring AbbVie, AstraZeneca, ...
Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect ...
Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...
Explore the Latest Research Peptides from Biotech Labz Supply Sebastopol, United States – January 4, 2026 / Biotech Labz Supply / Biotech Labz Supply has revealed an exciting enhancement of its ...
The University of Pennsylvania, biotech firm BioNTech, and Osage University Partners, a venture capital firm in Bala Cynwyd, ...
One of Cincinnati's best-funded startups has raised an additional $30 million, which will help it accelerate its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback